Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine

Fish and Shellfish Immunology

Volumn 39, Issue 1, 2014, Pages 8-16

  Ma, Jimei ^a   Xu, Jinmei ^a   Guan, Lingyu ^a   Hu, Tianjian ^a   Liu, Qin ^a   Xiao, Jingfan ^a   Zhang, Yuanxing ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antigen delivery; Bacterial vector vaccine; Cell penetrating peptides; Edwardsiella tarda

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; CELL PENETRATING PEPTIDE; ESCHERICHIA COLI PROTEIN; LYSIS PROTEIN, E COLI; RECOMBINANT VACCINE;

ANIMAL; BACTERIOLYSIS; EDWARDSIELLA TARDA; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FISH DISEASE; GENETICS; IMMUNOLOGY; METABOLISM; PLASMID; PROMOTER REGION; RANDOMIZATION; VETERINARY; ZEBRA FISH;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BACTERIOLYSIS; CELL-PENETRATING PEPTIDES; EDWARDSIELLA TARDA; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FISH DISEASES; PLASMIDS; PROMOTER REGIONS, GENETIC; RANDOM ALLOCATION; VACCINES, SYNTHETIC; ZEBRAFISH;

EID: 84899937970     PISSN: 10504648     EISSN: 10959947     Source Type: Journal    
DOI: 10.1016/j.fsi.2014.04.003     Document Type: Article

References (52)

1. Kong W., Clark-Curtiss J., Curtiss I.R. Utilizing Salmonella for antigen delivery.the aims and benefits of bacterial delivered vaccination. Expert Rev Vaccines 2013, 12(4):345-347.
2. Shata M.T., Stevceva L., Agwale S., Lewis G.K., Hone D.M. Recent advances with recombinant bacterial vaccine vectors. Mol Med Today 2000, 6(2):66-71.
3. Spreng S., Dietrich G., Weidinger G. Rational design of Salmonella-based vaccination strategies. Methods 2006, 38(2):133-143.
4. Galen J., Levine M. Can a 'flawless' live vector vaccine strain be engineered?. Trends Microbiol 2001, 9(8):372-376.
5. Guan L., Mu W., Champeimont J., Wang Q., Wu H., Xiao J., et al. Iron-regulated lysis of recombinant Escherichia coli in host releases protective antigen and confers biological containment. Infect Immun 2011, 79(7):2608-2618.
6. Jones S.W., Christison R., Bundell K., Voyce C.J., Brockbank S.M., Newham P., et al. Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol 2005, 145(8):1093-1102.
7. Wadia J.S., Dowdy S.F. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Adv Drug Deliv Rev 2005, 57(4):579-596.
8. Foerg C., Merkle H.P. On the biomedical promise of cell penetrating peptides.limits versus prospects. JPharm Sci 2008, 97(1):144-162.
9. Fonseca S.B., Pereira M.P., Kelley S.O. Recent advances in the use of cell-penetrating peptides for medical and biological applications. Adv Drug Deliv Rev 2009, 61(11):953-964.
10. Järver P., Mäger I., Langel Ü. Invivo biodistribution and efficacy of peptide mediated delivery. Trends Pharmacol Sci 2010, 31(11):528-535.
11. Brooks N.A., Pouniotis D.S., Sheng K.C., Apostolopoulos V., Pietersz G.A. Amembrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice. Biochim Biophys Acta 2010, 1798(12):2286-2295.
12. Shibagaki N., Udey M.C. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. JImmunol 2002, 168(5):2393-2401.
13. Brooks N.A., Pouniotis D.S., Tang C.K., Apostolopoulos V., Pietersz G.A. Cell-penetrating peptides.application in vaccine delivery. Biochim Biophys Acta 2010, 1805(1):25-34.
14. Apostolopoulos V., Pouniotis D.S., van Maanen P.J., Andriessen R.W., Lodding J., Xing P.X., et al. Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses. Vaccine 2006, 24(16):3191-3202.
15. Bury N.R., Grosell M. Waterborne iron acquisition by a freshwater teleost fish, zebrafish Danio rerio. JExp Biol 2003, 206:3529-3535.
16. Payne S.M. Iron acquisition in microbial pathogenesis. Trends Microbiol 1993, 1:66-69.
17. Stojiljkovic I., Baumler A.J., Hantke K. Fur regulon in gram-negative bacteria.identification and characterization of new iron-regulated Escherichia coli genes by a fur titration assay. JMol Biol 1994, 236:531-545.
18. Thune R.L., Stanley L.A., Cooper R.K. Pathogenesis of Gram-negative bacterial infections in warmwater fish. Annu Rev Fish Dis 1993, 3:37-68.
19. Wang I.K., Kuo H.L., Chen Y.M., Lin C.L., Chang H.Y., Chuang F.R., et al. Extraintestinal manifestations of Edwardsiella tarda infection. Int J Clin Pract 2005, 59:917-921.
20. Zhang M., Wu H., Li X., Yang M., Chen T., Wang Q., et al. Edwardsiella tarda flagellar protein FlgD.a protective immunogen against edwardsiellosis. Vaccine 2012, 30(26):3849-3856.
21. Vivés E., Brodin P., Lebleu B. Atruncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. JBiol Chem 1997, 272(25):16010-16017.
22. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. JBiol Chem 1994, 269(14):10444-10450.
23. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 1997, 88(2):223-233.
24. Elmquist A., Lindgren M., Bartfai T., Langel Ü. VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 2001, 269(2):237-244.
25. Park Y.J., Chang L.C., Liang J.F., Moon C., Chung C.P., Yang V.C. Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery.invitro and invivo study. FASEB J 2005, 19:1555-1557.
26. Schmidt M.C., Rothen-Rutishauser B., Rist B., Beck-Sickinger A., Wunderli-Allenspach H., Rubas W. Translocation of human calcitonin in respiratory nasal epithelium is associated with self-assembly in lipid membrane. Biochemistry 1998, 37(47):16582-16590.
27. Morris M.C., Depollier J., Mery J., Heitz F., Divita G. Apeptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 2001, 19(12):1173-1176.
28. Morris M.C., Vidal P., Chaloin L., Heitz F., Divita G. Anew peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 1997, 25(14):2730-2736.
29. Wyman T.B., Nicol F., Zelphati O., Scaria P.V., Plank C., Szoka F.C. Design, synthesis and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 1997, 36(10):3008-3017.
30. Yu H.H., Nakase I., Pujals S., Hirose H., Tanaka G., Katayama S., et al. Expressed protein ligation for the preparation of fusion proteins with cell penetrating peptides for endotoxin removal and intracellular delivery. Biochim Biophys Acta 2010, 1798(12):2249-2257.
31. Bechinger B. Towards membrane protein design.pH-sensitive topology of histidine-containing polypeptides. JMol Biol 1996, 263(5):768-775.
32. Pressley M.E., Phelan P.R., Witten P.E., Mellon M.T., Kim C.H. Pathogenesis and inflammatory response to Edwardsiella tarda infection in the zebra fish. Dev Comp Immunol 2005, 29(6):501-513.
33. Shin M.C., Zhang J., David A.E., Trommer W.E., Kwon Y.M., Min K.A., et al. Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity. JControl Release 2013, 172(1):169-178.
34. Krautwald S., Ziegler E., Tiede K., Pust R., Kunzendorf U. Transduction of the TAT-FLIP fusion protein results in transient resistance to Fas-induced apoptosis invivo. JBiol Chem 2004, 279(42):44005-44011.
35. Pouniotis D.S., Esparon S., Apostolopoulos V., Pietersz G.A. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways. Immunol Cell Biol 2011, 89(8):904-913.
36. Madani F., Lindberg S., Langel U., Futaki S., Gräslund A. Mechanisms of cellular uptake of cell-penetrating peptides. JBiophys 2011, 2011:414729.
37. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004, 10(3):310-315.
38. Liu B.R., Huang Y.W., Winiarz J.G., Chiang H.J., Lee H.J. Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. Biomaterials 2011, 32(13):3520-3537.
39. Viehl C.T., Tanaka Y., Chen T., Frey D.M., Tran A., Fleming T.P., et al. Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells. Breast Cancer Res Treat 2005, 91(3):271-278.
40. Pouniotis D.S., Apostolopoulos V., Pietersz G.A. Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway. Immunology 2006, 117(3):329-339.
41. Zhang T.T., Kang T.H., Ma B., Xu Y., Hung C.F., Wu T.C. LAH4 enhances CD8+ T cell immunity of protein/peptide-based vaccines. Vaccine 2012, 30(4):784-793.
42. Mitsui H., Inozume T., Kitamura R., Shibagaki N., Shimada S. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity. JInvest Dermatol 2006, 126(8):1804-1812.
43. Gamer M., Fröde D., Biedendieck R., Stammen S., Jahn D. AT7 RNA polymerase-dependent gene expression system for Bacillus megaterium. Appl Microbiol Biotechnol 2009, 82(6):1195-1203.
44. Salam M.A., Katz J., Zhang P., Hajishengallis G., Michalek S.M. Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system. Vaccine 2006, 24(23):5003-5015.
45. 2+ as an extracellular signal.environmental regulation of Salmonella virulence. Cell 1996, 84(1):165-174.
46. Mu W., Guan L., Yan Y., Liu Q., Zhang Y. Anovel invivo inducible expression system in Edwardsiella tarda for potential application in bacterial polyvalence vaccine. Fish Shellfish Immunol 2011, 31(6):1097-1105.
47. Harms J.S., Durward M.A., Magnani D.M., Splitter G.A. Evaluation of recombinant invasive, non-pathogenic Escherichia coli as a vaccine vector against the intracellular pathogen, Brucella. JImmune Based Ther Vaccines 2009, 7:1.
48. Critchley R.J., Jezzard S., Radford K.J., Goussard S., Lemoine N.R., Grillot-Courvalin C., et al. Potential therapeutic applications of recombinant, invasive E.coli. Gene Ther 2004, 11(15):1224-1233.
49. Muhammad A., Champeimont J., Mayr U.B., Lubitz W., Kudela P. Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications. Expert Rev Vaccines 2012, 11(1):97-116.
50. Jalava K., Hensel A., Szostak M., Resch S., Lubitz W. Bacterial ghosts as vaccine candidates for veterinary applications. JControl Release 2002, 85(1-3):17-25.
51. Mayr U.B., Walcher P., Azimpour C., Riedmann E., Haller C., Lubitz W. Bacterial ghosts as antigen delivery vehicles. Adv Drug Deliv Rev 2005, 57(9):1381-1391.
52. Kwon S.R., Nam Y.K., Kim S.K., Kim K.H. Protection of tilapia (Oreochromis mosambicus) from edwardsiellosis by vaccination with Edwardsiella tarda ghosts. Fish Shellfish Immunol 2006, 20(4):621-626.